Abstract:The t(4;11)(q21;q23) translocation is a hallmark of infant acute lymphoblastic leukemia (ALL), which results in the fusion of the MLL gene on chromosome 11 and the AF4 gene on chromosome 4. MLL-AF4 fusion is the most common consequence of chromosomal translocations in infant leukemia and is associated with a poor prognosis. To identify leukemia-related genes, we used the SAGE technique to compare gene expression profiles between two MLL-AF4 patient samples and one normal sample (CD19+ progenitor B cells; 216,464 tags in total). We identified 61 candidate genes that appear to be abnormally expressed in the leukemia samples (29 up- and 32 down-regulated). Remarkably, we found that many candidate genes appear to play important role in the development of B cells. In addition, many candidate genes can bind with and/or regulate other candidates in the candidate gene list. For example, SYK, BTK and BLNK can bind directly and regulate each other. SYK can also bind directly with TNFRSF1B. In addition, EBF may positively regulate BLK, while BLK can bind directly with BTK. All six of these genes are significantly down-regulated in MLL-AF4 leukemia samples. BTK, SYK and BLK are tyrosine kinases. BTK (B-cell progenitor tyrosine kinase) is a key regulator in B-lymphocyte differentiation and activation. BLK (B-lymphocyte-specific tyrosine kinase) is expressed only in B lymphocytes, and controls pre-B cell development. SYK (spleen tyrosine kinase) is widely expressed in hematopoietic cells, which can phosphorylate BLNK (B-cell linker protein). BLNK represents a central linker protein that bridges the B-cell receptor-associated kinases and may regulate B-cell function and development. EBF (early B-cell factor) is a tissue-specific and differentiation stage-specific DNA-binding protein, and mice lacking Ebf are unable develop B lymphoid cells. TNFRSF1B is strongly expressed on stimulated T and B lymphocytes. Moreover, previous studies indicate that BTK, BLK, SYK, BLNK and TNFRSF1B can positively regulate apoptosis, while BTK can also positively regulate differentiation. Thus, their down-regulation may inhibit apoptosis and differentiation, and thereby contribute to leukemogenesis. In contrast, GNA12, a transforming oncogene which can enhance proliferation and transformation and can bind directly with BTK, is significantly up-regulated in MLL-AF4 leukemia cells. Its up-regulation may also be important to leukemogenesis. Taken together, the deregulation of the important candidate genes may contribute to leukemogenesis through inhibiting apoptosis and differentiation while promoting proliferation of hematopoietic cells. We have validated the expression patterns of the candidate genes with real-time quantitative RT-PCR and are studying the functions and pathways of the validated candidate genes using RNAi and retrovirus transduction over-expression methods. In addition, we will also establish knock-in or knock-out mouse models for the most promising functional candidate genes to see the effect on the development of leukemia. Our studies will provide important insights into the complex functional pathways related to MLL rearrangements in the development of acute lymphoblastic leukemia, which may lead to more effective therapy for these leukemias.

High-Resolution Analyses of Genetic and Epigenetic Aberrations in Infant Leukemia with Mll Rearrangement

MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

The Landscape of Somatic Mutations in Infant MLL-rearranged Acute Lymphoblastic Leukemias.

[Study on Clinical and Biological Characteristics of Childhood Acute Leukemia with MLL Gene Rearrangements].

[Clinical and Experimental Studies of Childhood Acute Myeloid Leukemia with 11q23/mll Rearrangements].

Analysis of Methylation Level and Clinical Characteristics of Juvenile Myelomonocytic Leukemia

Identification of Genes Abnormally Expressed in Human Mll-Af4 Leukemia.

Detection of MLL Gene Rearrangements in Childhood Acute Leukemia and Its Clinical Significance

Relatively Favorable Prognosis for MLL-rearranged Childhood Acute Leukemia with Reciprocal Translocations

[Detection and Clinical Features of MLL Gene Rearrangement in Adult Patients with Acute Leukemia].

Abstract 4869: Whole Genome Sequence Analysis of MLL Rearranged Infant Acute Lymphoblastic Leukemias Reveals Remarkably Few Somatic Mutations: A Report from the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

[Clinical and Molecular Biologic Characteristics of 36 Cases of Leukemia with 11Q23/mll].

The MLL recombinome of acute leukemias in 2017

Clinical and Molecular Biologic Characteristics of Childhood Acute Leukemia with Mixed Lineage Leukemia Gene Rearrangement

[Mutational Detection of Full-Length Mixed Lineage Leukemia Gene in Patients with De Novo AML-M4 and M5].

Global Increase in H3K79 Dimethylation in Murine and Human MLL-AF4 Lymphoblastic Leukemias.

[Identification of Gene Rearrangements in Childhood Leukemia by Using a Multiplex Polymerase Chain Reaction-Microarray Approach].

Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement

Detection of Rearrangements of Mixed Lineage Leukemia Gene and Its Clinical Significance

A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia